A study titled "Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients" was published in the Neuropsychopharmacology journal by a team of researchers in the Department of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, University of São Paulo, SP, Brazil.
Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol (CBD), researchers argued, has shown anxiolytic effects both in humans and in animals. During the double-blind randomized study, researchers administered a single dose of either CBD (600mg) or a placebo to 24 patients, then asking them to simulate a public speaking test.
When analyzing the behavioral outcome and physiological measures, researchers concluded that "pretreatment with CBD significantly reduced anxiety, cognitive impairment and discomfort in their speech performance, and significantly decreased alert in their anticipatory speech. The placebo group presented higher anxiety, cognitive impairment, discomfort, and alert levels when compared with the control group."
To read the study, please see the link here